Re: Niraparib and Abiraterone Acetate for Metastatic Castration-resistant Prostate Cancer

doi:10.1016/j.eururo.2023.09.012

Comment

. 2024 Jan;85(1):96-97.

doi: 10.1016/j.eururo.2023.09.012. Epub 2023 Sep 27.

Re: Niraparib and Abiraterone Acetate for Metastatic Castration-resistant Prostate Cancer

Edward Lambert¹, Morgan Rouprêt²

Affiliations

¹ GRC 5 Predictive Onco-Uro, Sorbonne University, Department of Urology, Pitie-Salpetriere Hospital, AP-HP, Paris, France; Department of Urology, Onze-Lieve-Vrouw Hospital, Aalst, Belgium; Junior EAU Robotic Urology Section/Young Academic Urologists Working Group on Robot-Assisted Surgery, European Association of Urology, Arnhem, The Netherlands.
² GRC 5 Predictive Onco-Uro, Sorbonne University, Department of Urology, Pitie-Salpetriere Hospital, AP-HP, Paris, France. Electronic address: mroupret@gmail.com.

PMID: 37775360
DOI: 10.1016/j.eururo.2023.09.012

Comment

Re: Niraparib and Abiraterone Acetate for Metastatic Castration-resistant Prostate Cancer

Edward Lambert et al. Eur Urol. 2024 Jan.

. 2024 Jan;85(1):96-97.

doi: 10.1016/j.eururo.2023.09.012. Epub 2023 Sep 27.

Authors

Edward Lambert¹, Morgan Rouprêt²

Affiliations

¹ GRC 5 Predictive Onco-Uro, Sorbonne University, Department of Urology, Pitie-Salpetriere Hospital, AP-HP, Paris, France; Department of Urology, Onze-Lieve-Vrouw Hospital, Aalst, Belgium; Junior EAU Robotic Urology Section/Young Academic Urologists Working Group on Robot-Assisted Surgery, European Association of Urology, Arnhem, The Netherlands.
² GRC 5 Predictive Onco-Uro, Sorbonne University, Department of Urology, Pitie-Salpetriere Hospital, AP-HP, Paris, France. Electronic address: mroupret@gmail.com.

PMID: 37775360
DOI: 10.1016/j.eururo.2023.09.012

No abstract available

PubMed Disclaimer

Comment on

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer.
Chi KN, Rathkopf D, Smith MR, Efstathiou E, Attard G, Olmos D, Lee JY, Small EJ, Pereira de Santana Gomes AJ, Roubaud G, Saad M, Zurawski B, Sakalo V, Mason GE, Francis P, Wang G, Wu D, Diorio B, Lopez-Gitlitz A, Sandhu S; MAGNITUDE Principal Investigators. Chi KN, et al. J Clin Oncol. 2023 Jun 20;41(18):3339-3351. doi: 10.1200/JCO.22.01649. Epub 2023 Mar 23. J Clin Oncol. 2023. PMID: 36952634 Free PMC article. Clinical Trial.

Cited by

The importance of second-look ureteroscopy implementation in the conservative management of upper tract urothelial carcinoma.
Gallioli A, Basile G, Territo A, Verri P, Gaya JM, Sanguedolce F, Aumatell J, Izquierdo P, Uleri A, Diana P, Huguet J, Algaba F, Palou J, Breda A. Gallioli A, et al. World J Urol. 2023 Oct;41(10):2743-2749. doi: 10.1007/s00345-023-04577-8. Epub 2023 Sep 5. World J Urol. 2023. PMID: 37668716

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Re: Niraparib and Abiraterone Acetate for Metastatic Castration-resistant Prostate Cancer

Affiliations

Re: Niraparib and Abiraterone Acetate for Metastatic Castration-resistant Prostate Cancer

Authors

Affiliations

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources